LDL-C Targets in Secondary Prevention: How Low Should We Go?

<h3>Abstract</h3><p dir="ltr">The benefits of lowering low-density lipoprotein cholesterol (LDL-C), mainly using high-intensity statin therapy, and its impact on decreasing the recurrence of atherosclerotic cardiovascular disease (ASCVD) in secondary prevention has been w...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Karim Bayoumy (3496688) (author)
مؤلفون آخرون:	Mohammed Gaber (14151942) (author), Preethi Mani (14151945) (author), Rishi Puri (6090599) (author), Eoin Donnellan (12122073) (author), Leslie Cho (8859803) (author), Donald Clark (14151948) (author), Seth S. Martin (8164878) (author), Mohamed B. Elshazly (14151951) (author)
منشور في:	2019
الموضوعات:	Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Clinical guidelines LDL lowering Secondary prevention PCSK9 inhibitors Adverse effects
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

LDL-C Targets in Secondary Prevention: How Low Should We Go?

مواد مشابهة